Agreement Encompasses Development of Patented, Controlled Delivery Natural Supplements
DECATUR, Ill., March 29 -- Archer Daniels Midland Company (NYSE: ADM) and Nutraceutix, Inc. (OTC Bulletin Board: NUTX), have announced the execution of an exclusive licensing agreement for ADM to use Nutraceutix' patented Controlled Delivery Technology (CDT(TM)) to develop and market dietary supplements. ADM will market its products using this technology on an exclusive global basis to dietary supplement manufacturers.
The first product to be marketed is Novasoy(R) Daily Dose(TM). This once- a-day supplement provides a consistent, steady delivery of natural-based soy isoflavones (a phytoestrogen) throughout the day, much like a woman's body naturally produces estrogen. Results of a recent clinical study published in the March 2002 Journal of American College of Obstetricians and Gynecologists concluded that women who took isoflavones three times a day had significant reduction in a variety of menopausal symptoms. In addition, it was determined that isoflavones may help support a healthy cardiovascular system.(1) Novasoy(R) Daily Dose(TM) is designed to provide all the benefits of isoflavones in a convenient, single daily dose.
"Nutraceutix' CDT(TM) technology allows us to tailor the biological delivery of dietary supplements to maximize its health benefits and, in most cases, better simulate the natural function of the human body. We expect to see applications in an entire range of dietary supplements," stated Tony DeLio, ADM Vice President, Marketing and External Affairs. "This represents a significant advancement in supplement technology and demonstrates ADM's continued commitment to bringing innovation and science to supplements and functional foods."
According to David T. Howard, CEO of Nutraceutix, "The Nutraceutix and ADM alliance marries ADM's expertise in the natural nutraceutical market with Nutraceutix' patented CDT to develop better performing dietary supplements. ADM's global reach allows us to make these products available worldwide."
ADM Natural Health and Nutrition's mission is to discover and manufacture scientifically proven ingredients from natural sources that promote health and well being. Its products include Novasoy(R) isoflavones, vitamin E, CardioAid(TM) products, NutriSoy(R) soy protein, Soy7(TM) products and other soy foods.
Archer Daniels Midland Company (NYSE: ADM) is a world leader in agricultural processing. The Company is one of the world's largest processors of soybeans, corn, wheat and cocoa. ADM is also a leader in soy meal and oil, ethanol, high fructose corn syrup (HFCS) and flour. In addition, ADM is building a position in such value-added products as specialty food ingredients, bioproducts and nutraceuticals. Headquartered in Decatur, Illinois, ADM has over 22,000 employees, 275 processing plants and net sales for the fiscal year ended June 30, 2001, of $20.1 billion. Additional information can be found on ADM's web site at http://www.admworld.com .
Based in Redmond, Washington, Nutraceutix, Inc. is a biopharmaceutical company that leverages specialized knowledge, proprietary and patented products and technologies such as LiveBac(R) Probiotics and the patented CDT Controlled Delivery Technology platform in order to introduce distinctive and novel OTC products, prescription drugs and dietary supplements. Nutraceutix has established partnerships with pharma, OTC, and supplement companies to co- develop new products with enhanced benefits. Additional information can be found on the Nutraceutix web site at http://www.nutraceutix.com or by calling 1/800-548-3222.